These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 20552588

  • 1. Clinostatic hypertension and orthostatic hypotension.
    Lagi A, Spini S.
    Clin Cardiol; 2010 Jun; 33(6):E10-5. PubMed ID: 20552588
    [Abstract] [Full Text] [Related]

  • 2. New developments in the management of neurogenic orthostatic hypotension.
    Biaggioni I.
    Curr Cardiol Rep; 2014 Nov; 16(11):542. PubMed ID: 25303896
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Orthostatic Hypotension in the Hypertensive Patient.
    Biaggioni I.
    Am J Hypertens; 2018 Nov 13; 31(12):1255-1259. PubMed ID: 29982276
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Clinical benefit of midodrine hydrochloride in symptomatic orthostatic hypotension: a phase 4, double-blind, placebo-controlled, randomized, tilt-table study.
    Smith W, Wan H, Much D, Robinson AG, Martin P.
    Clin Auton Res; 2016 Aug 13; 26(4):269-77. PubMed ID: 27372462
    [Abstract] [Full Text] [Related]

  • 7. Orthostatic Hypotension in Adults With Hypertension: A Scientific Statement From the American Heart Association.
    Juraschek SP, Cortez MM, Flack JM, Ghazi L, Kenny RA, Rahman M, Spikes T, Shibao CA, Biaggioni I, American Heart Association Council on Hypertension.
    Hypertension; 2024 Mar 13; 81(3):e16-e30. PubMed ID: 38205630
    [Abstract] [Full Text] [Related]

  • 8. Orthostatic hypotension: evaluation and treatment.
    Maule S, Papotti G, Naso D, Magnino C, Testa E, Veglio F.
    Cardiovasc Hematol Disord Drug Targets; 2007 Mar 13; 7(1):63-70. PubMed ID: 17346129
    [Abstract] [Full Text] [Related]

  • 9. Midodrine for orthostatic hypotension: a systematic review and meta-analysis of clinical trials.
    Parsaik AK, Singh B, Altayar O, Mascarenhas SS, Singh SK, Erwin PJ, Murad MH.
    J Gen Intern Med; 2013 Nov 13; 28(11):1496-503. PubMed ID: 23775146
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of Servo-Controlled Splanchnic Venous Compression in the Treatment of Orthostatic Hypotension: A Randomized Comparison With Midodrine.
    Okamoto LE, Diedrich A, Baudenbacher FJ, Harder R, Whitfield JS, Iqbal F, Gamboa A, Shibao CA, Black BK, Raj SR, Robertson D, Biaggioni I.
    Hypertension; 2016 Aug 13; 68(2):418-26. PubMed ID: 27271310
    [Abstract] [Full Text] [Related]

  • 11. Midodrine as adjunctive support for treatment of refractory hypotension in the intensive care unit: a multicenter, randomized, placebo controlled trial (the MIDAS trial).
    Anstey MH, Wibrow B, Thevathasan T, Roberts B, Chhangani K, Ng PY, Levine A, DiBiasio A, Sarge T, Eikermann M.
    BMC Anesthesiol; 2017 Mar 21; 17(1):47. PubMed ID: 28327122
    [Abstract] [Full Text] [Related]

  • 12. Effect of discontinuation of antihypertensive medication on orthostatic hypotension in older persons with mild cognitive impairment: the DANTE Study Leiden.
    Moonen JE, Foster-Dingley JC, de Ruijter W, van der Grond J, de Craen AJ, van der Mast RC.
    Age Ageing; 2016 Mar 21; 45(2):249-55. PubMed ID: 26758532
    [Abstract] [Full Text] [Related]

  • 13. Midodrine. A review of its therapeutic use in the management of orthostatic hypotension.
    McClellan KJ, Wiseman LR, Wilde MI.
    Drugs Aging; 1998 Jan 21; 12(1):76-86. PubMed ID: 9467688
    [Abstract] [Full Text] [Related]

  • 14. Delayed orthostatic hypotension: Severity of clinical symptoms and response to medical treatment.
    Byun JI, Moon J, Kim DY, Shin H, Sunwoo JS, Lim JA, Kim TJ, Lee WJ, Lee HS, Jun JS, Park KI, Lee ST, Jung KH, Jung KY, Kim M, Lee SK, Chu K.
    Auton Neurosci; 2018 Sep 21; 213():81-85. PubMed ID: 30005744
    [Abstract] [Full Text] [Related]

  • 15. Standing and Supine Blood Pressure Outcomes Associated With Droxidopa and Midodrine in Patients With Neurogenic Orthostatic Hypotension: A Bayesian Meta-analysis and Mixed Treatment Comparison of Randomized Trials.
    Chen JJ, Han Y, Tang J, Portillo I, Hauser RA, Dashtipour K.
    Ann Pharmacother; 2018 Dec 21; 52(12):1182-1194. PubMed ID: 29972032
    [Abstract] [Full Text] [Related]

  • 16. Efficacy of midodrine vs placebo in neurogenic orthostatic hypotension. A randomized, double-blind multicenter study. Midodrine Study Group.
    Low PA, Gilden JL, Freeman R, Sheng KN, McElligott MA.
    JAMA; 1997 Apr 02; 277(13):1046-51. PubMed ID: 9091692
    [Abstract] [Full Text] [Related]

  • 17. The Treatment of Primary Orthostatic Hypotension.
    Hale GM, Valdes J, Brenner M.
    Ann Pharmacother; 2017 May 02; 51(5):417-428. PubMed ID: 28092986
    [Abstract] [Full Text] [Related]

  • 18. Normalization of blood pressure in a patient with severe orthostatic hypotension and supine hypertension using clonidine.
    Brahmbhatt R, Baggaley P, Hockings B.
    Hypertension; 2001 Jun 02; 37(6):E24. PubMed ID: 11408403
    [No Abstract] [Full Text] [Related]

  • 19. Management of Orthostatic Hypotension in Parkinson's Disease.
    Fanciulli A, Leys F, Falup-Pecurariu C, Thijs R, Wenning GK.
    J Parkinsons Dis; 2020 Jun 02; 10(s1):S57-S64. PubMed ID: 32716319
    [Abstract] [Full Text] [Related]

  • 20. The patient with supine hypertension and orthostatic hypotension: a clinical dilemma.
    Naschitz JE, Slobodin G, Elias N, Rosner I.
    Postgrad Med J; 2006 Apr 02; 82(966):246-53. PubMed ID: 16597811
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.